Earning Analysis
Welcome to our in-depth analysis of STERIS plc(STE) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of STERIS plc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2026Q2 | 2025-11-05 | After Hours | 2.38 | 2.47 | +3.78 | 1.43B | 1.46B | +1.95 | +6.94 | +9.67 |
| FY2026Q1 | 2025-08-06 | After Hours | 2.32 | 2.34 | +0.86 | 1.36B | 1.39B | +2.08 | +6.79 | +10.19 |
| FY2025Q4 | 2025-05-14 | After Hours | 2.59 | 2.74 | +5.79 | 1.47B | 1.48B | +0.94 | +8.52 | +10.10 |
| FY2025Q3 | 2025-02-05 | After Hours | 2.32 | 2.32 | - | 1.38B | 1.37B | -0.93 | +2.09 | -0.78 |
| FY2025Q1 | 2024-08-06 | - | 2.01 | 2.03 | +1.00 | 1.27B | 1.28B | +0.67 | +0.54 | -1.66 |
| FY2024Q4 | 2024-05-08 | - | 2.41 | 2.41 | - | 1.41B | 1.50B | +6.29 | -1.31 | +10.87 |
| FY2024Q3 | 2024-02-07 | - | 2.17 | 2.22 | +2.30 | 1.35B | 1.40B | +3.49 | -0.02 | -0.62 |
| FY2024Q2 | 2023-11-07 | - | 2.05 | 2.03 | -0.98 | 1.30B | 1.34B | +3.31 | +0.34 | -7.02 |
| FY2024Q1 | 2023-08-01 | - | 1.86 | 2.00 | +7.53 | 1.21B | 1.28B | +6.39 | -0.68 | +0.28 |
| - | 2023-05-10 | - | 2.15 | 2.30 | +6.98 | - | - | - | +1.21 | +11.12 |
STE Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, STERIS plc reported performance for FY2026Q2, announced on 2025-11-05. The company achieved an EPS of 2.47, compared to analyst estimates of 2.38 by 3.78% . Revenue for the quarter reached 1.46B compared to expectations of 1.43B by 1.95% .
The stock price reacted with a 6.94% one-day change and a 9.67% five-day change following the earnings release. These movements reflect market reaction in STERIS plc growth trajectory and strategic initiatives.
STE Earnings Forecast
Looking ahead, STERIS plc(STE) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2026/Q3 project quarter revenue of 1.48B and an EPS of 2.53.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2026 have been Revise Upward by 0.11%, while EPS estimates have been Revise Upward by 1.06%. For the upcoming Q3 2026, revenue estimates have been adjusted Revise Downward by -0.1% . These revisions correlate with a 6.41% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in STERIS plc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between STE's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2026
Revise Upward
+0.11%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
+1.06%
In Past 3 Month
Revenue Estimates for Q3 2026
Revise Downward
-0.1%
In Past 3 Month
Stock Price
Go Up
+6.41%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2026
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2026:5.92B
--
EPS Estimate-Annual FY 2026:10.21
—
Stock Price261.02
STE Revenue and EPS Performance: A Historical Perspective
STERIS plc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2026Q2 (2025-11-05,After Hours):
EPS: 2.47 (Actual) vs.2.38 (Estimate) (3.78%)
Revenue: 1.46B (Actual) vs. 1.43B (Estimate) (1.95%)
Price Reaction: 6.94%(1-Day), 9.67%(5-Day)
FY2026Q1 (2025-08-06,After Hours):
EPS: 2.34 (Actual) vs.2.32 (Estimate) (0.86%)
Revenue: 1.39B (Actual) vs. 1.36B (Estimate) (2.08%)
Price Reaction: 6.79%(1-Day), 10.19%(5-Day)
FY2025Q4 (2025-05-14,After Hours):
EPS: 2.74 (Actual) vs.2.59 (Estimate) (5.79%)
Revenue: 1.48B (Actual) vs. 1.47B (Estimate) (0.94%)
Price Reaction: 8.52%(1-Day), 10.10%(5-Day)
Earnings Reaction
The chart below shows how STE performed 10 days before and after its earnings report, based on data from the past quarters. Typically, STE sees a -1.47% change in stock price 10 days leading up to the earnings, and a +3.82% change 10 days following the report. On the earnings day itself, the stock moves by -0.15%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed 6.94% on the day following the earnings release and then changed by 4.74% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
STERIS plc (STE) Q2 2026 Earnings Call Summary
Positive
2025-11-06
The earnings call reflects strong financial performance with a 15% increase in EPS and robust free cash flow. The company anticipates 8-9% revenue growth and maintains strong growth across segments. Positive factors include increased EBIT margins and solid growth in healthcare and AST services. Despite headwinds from tariffs and inflation, the guidance remains optimistic, supported by strategic expansions and stable demand. The Q&A session reinforced management's confidence in sustained growth, though some responses lacked detail. Given these factors, a positive stock price movement is expected.
STERIS plc (STE) Q1 2026 Earnings Call Summary
Positive
2025-08-07
The earnings call indicates strong financial performance with increased net income, free cash flow, and dividends. Despite tariff challenges, the company maintains growth expectations and reports strong order growth across segments. The Q&A reveals confidence in market positions and future prospects, with no major concerns raised by analysts. The positive sentiment is supported by organic revenue growth, margin improvements, and strategic cash management plans, suggesting a likely stock price increase in the short term.
STERIS plc (STE) Q3 2024 Earnings Call Summary
Neutral
2025-02-06
The earnings call summary presents a mixed picture: strong growth in AST and healthcare segments, but declines in life sciences and capital equipment revenue. The Q&A highlighted optimism in bioprocessing demand but revealed management's vague responses on tariffs and future margins, creating uncertainty. Flat profit margins and expected legal expenses are concerns. Overall, the positive and negative factors offset each other, leading to a neutral sentiment.
STERIS plc (STE) Q2 2025 Earnings Call Summary
Neutral
2024-11-07
The earnings call summary shows mixed results: a 7% revenue increase and strong growth in certain segments, but declining margins due to labor and energy costs. The Q&A section reveals concerns about losses and AST performance, yet optimism about bioprocessing and healthcare backlog. Adjusted EPS guidance remains valid, but margin pressures and lack of details on M&A and litigation add uncertainty. Overall, the sentiment is neutral due to balanced positive and negative factors.
STERIS plc (STE) Q1 2025 Earnings Call Summary
Neutral
2024-08-07
The earnings call presents a mixed outlook. Financial performance shows revenue and EPS growth, but EBIT margins are pressured by inflation. Positive elements include a dividend increase and debt reduction. However, risks like regulatory challenges, supply chain issues, and economic factors temper enthusiasm. The Q&A reveals cautious optimism but lacks clarity on certain aspects. Overall, the neutral sentiment reflects balancing strong financial metrics against potential risks and uncertainties.
People Also Watch
FAQ
What were the key highlights of STE’s latest earnings report for FY2026Q2?
How did STE’s stock price react after the FY2026Q2 earnings release?
What are the revenue and EPS estimates for STE for 2026/Q3?
How does STE’s stock price correlate with earnings forecast revisions?
What should investors expect from STE’s next earnings report?